CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 70 enrolled
Drug / intervention
MRIdevice
Likely dose
Not stated in record
Key inclusion· 6
  • Single pore nipple discharge that is neither green nor milky
  • Normal mammography (at least 2 views, including retro-areolar if needed)
  • Normal initial ultrasound
  • Age over 18 years
Key exclusion· 1
  • Physiological milky or green discharge

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02819362
NCT02819362N/ACompleted

Benefit of a Diagnostic MRI in Case of Pathological Nipple Discharge With Normal Mammography / Ultrasound.

Institut Bergonié·observational·Posted Jun 30, 2016·Updated Oct 15, 2025

In Brief

An observational study evaluating MRI for Breast Cancer. Completed, enrolled 70 participants across 1 site.

Detailed Summary

Benefit of MRI in pathological nipple discharge.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Cancer
CountriesFrance

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJun 30, 2016
Enrollment StartApr 1, 2014
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 2.7 yearsPosted 10.0 years ago

Interventions

MRIdevice

The magnetic resonance imaging (MRI) will be performed before the two-step surgery: a ductal-MRI sequence (highly weighted sagittal T2) - followed by sequence with axial plane, T2, T1, injection in dynamic sequences, subtractions.